NORDTREAT

NORDTREAT - The Nordic IBD treatment strategy trial

NORDTREAT is a Nordic collaborative treatment strategy trial, built on a novel biosignature, that aims to stratify newly diagnosed patients with inflammatory bowel disease (IBD) based on their future disease course and adapt the treatment accordingly.

The last patients have now completed their final visit, and the study database was recently closed. Analyses are about to begin — stay tuned for the results.